JP2014051457A - Powder cosmetic - Google Patents
Powder cosmetic Download PDFInfo
- Publication number
- JP2014051457A JP2014051457A JP2012197203A JP2012197203A JP2014051457A JP 2014051457 A JP2014051457 A JP 2014051457A JP 2012197203 A JP2012197203 A JP 2012197203A JP 2012197203 A JP2012197203 A JP 2012197203A JP 2014051457 A JP2014051457 A JP 2014051457A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- oil
- fragrance
- hydrogenated castor
- polyoxyethylene hydrogenated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 76
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- -1 polyoxyethylene Polymers 0.000 claims abstract description 47
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 30
- 239000004359 castor oil Substances 0.000 claims abstract description 29
- 235000019438 castor oil Nutrition 0.000 claims abstract description 28
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 28
- 239000000049 pigment Substances 0.000 claims abstract description 16
- 239000004606 Fillers/Extenders Substances 0.000 claims abstract description 12
- 239000000796 flavoring agent Substances 0.000 claims abstract description 10
- 235000019634 flavors Nutrition 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000003205 fragrance Substances 0.000 claims description 32
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims description 14
- 239000000454 talc Substances 0.000 claims description 11
- 229910052623 talc Inorganic materials 0.000 claims description 11
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims description 7
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 claims description 5
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 5
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 3
- 240000005385 Jasminum sambac Species 0.000 claims description 3
- 240000001972 Gardenia jasminoides Species 0.000 claims description 2
- 244000182022 Salvia sclarea Species 0.000 claims description 2
- 235000002911 Salvia sclarea Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 239000002304 perfume Substances 0.000 abstract description 9
- 230000007850 degeneration Effects 0.000 abstract 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 description 7
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 7
- 239000010445 mica Substances 0.000 description 6
- 229910052618 mica group Inorganic materials 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- 239000004677 Nylon Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241001237961 Amanita rubescens Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000035985 Body Odor Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010040904 Skin odour abnormal Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- BGCIAWBDYRWKEK-UHFFFAOYSA-N (1-butylcyclohexyl) acetate Chemical group CCCCC1(OC(C)=O)CCCCC1 BGCIAWBDYRWKEK-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HLCSDJLATUNSSI-JXMROGBWSA-N (2e)-3,7-dimethylocta-2,6-dienenitrile Chemical compound CC(C)=CCC\C(C)=C\C#N HLCSDJLATUNSSI-JXMROGBWSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 1
- QTVUWYLBNFIRDR-UHFFFAOYSA-N 1,2-diethoxy-3,7-dimethylocta-2,6-diene Chemical compound CCOCC(OCC)=C(C)CCC=C(C)C QTVUWYLBNFIRDR-UHFFFAOYSA-N 0.000 description 1
- 239000001709 1,2-dimethylcyclohex-3-ene-1-carbaldehyde Substances 0.000 description 1
- NAKMDRNNFRKBHS-UHFFFAOYSA-N 1-[4-(5-amino-2-chlorophenyl)piperazin-1-yl]ethanone Chemical group C1CN(C(=O)C)CCN1C1=CC(N)=CC=C1Cl NAKMDRNNFRKBHS-UHFFFAOYSA-N 0.000 description 1
- WNJSKZBEWNVKGU-UHFFFAOYSA-N 2,2-dimethoxyethylbenzene Chemical compound COC(OC)CC1=CC=CC=C1 WNJSKZBEWNVKGU-UHFFFAOYSA-N 0.000 description 1
- IEZPIUQRQRWIFE-UHFFFAOYSA-N 2,4,6-trimethyl-4-phenyl-1,3-dioxane Chemical compound O1C(C)OC(C)CC1(C)C1=CC=CC=C1 IEZPIUQRQRWIFE-UHFFFAOYSA-N 0.000 description 1
- XSNQECSCDATQEL-SECBINFHSA-N 2,6-dimethyl-7-octen-2-ol Chemical compound C=C[C@@H](C)CCCC(C)(C)O XSNQECSCDATQEL-SECBINFHSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- DSVUBXQDJGJGIC-UHFFFAOYSA-N 3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(I)=C1OC1=C(I)C(O)=CC=C21 DSVUBXQDJGJGIC-UHFFFAOYSA-N 0.000 description 1
- FRUPGGSBENIUTJ-UHFFFAOYSA-N 3,5,6,6-tetramethyl-4-methylideneheptan-2-one Chemical compound CC(=O)C(C)C(=C)C(C)C(C)(C)C FRUPGGSBENIUTJ-UHFFFAOYSA-N 0.000 description 1
- JNAWJUOCXKIHHG-UHFFFAOYSA-N 3,7-dimethyloct-2-en-1-ol Chemical compound CC(C)CCCC(C)=CCO JNAWJUOCXKIHHG-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- UJVMVSBNTJTGOO-UHFFFAOYSA-N 3-chloro-n-(5-fluoro-2-methylphenyl)propanamide Chemical compound CC1=CC=C(F)C=C1NC(=O)CCCl UJVMVSBNTJTGOO-UHFFFAOYSA-N 0.000 description 1
- NGYMOTOXXHCHOC-UHFFFAOYSA-N 3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pentan-2-ol Chemical compound CC(O)C(C)CCC1CC=C(C)C1(C)C NGYMOTOXXHCHOC-UHFFFAOYSA-N 0.000 description 1
- VPXWZHXOBQZDNM-UHFFFAOYSA-N 4,4-dimethylcyclohex-2-ene-1-carbaldehyde Chemical compound CC1(CCC(C=O)C=C1)C VPXWZHXOBQZDNM-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HFNGYHHRRMSKEU-UHFFFAOYSA-N 4-Methoxybenzyl acetate Chemical group COC1=CC=C(COC(C)=O)C=C1 HFNGYHHRRMSKEU-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- HZPKNSYIDSNZKW-UHFFFAOYSA-N Ethyl 2-methylpentanoate Chemical compound CCCC(C)C(=O)OCC HZPKNSYIDSNZKW-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- GPMLJOOQCIHFET-UHFFFAOYSA-N Rhubafuran Chemical compound C1OC(C)CC1(C)C1=CC=CC=C1 GPMLJOOQCIHFET-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- CUSKZEYVILQFHM-UHFFFAOYSA-N [Bi].O=O Chemical compound [Bi].O=O CUSKZEYVILQFHM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- JZQOJFLIJNRDHK-CMDGGOBGSA-N alpha-irone Chemical compound CC1CC=C(C)C(\C=C\C(C)=O)C1(C)C JZQOJFLIJNRDHK-CMDGGOBGSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001444 canarium indicum l. oil Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000010633 clary sage oil Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 239000001449 ethyl (2R)-2-methylpentanoate Substances 0.000 description 1
- XWEOGMYZFCHQNT-UHFFFAOYSA-N ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate Chemical compound CCOC(=O)CC1(C)OCCO1 XWEOGMYZFCHQNT-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 229940093858 ethyl acetoacetate Drugs 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000001469 lavandula hydrida abrial herb oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- KWVISVAMQJWJSZ-VKROHFNGSA-N solasodine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CN1 KWVISVAMQJWJSZ-VKROHFNGSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- LLZRNZOLAXHGLL-UHFFFAOYSA-J titanic acid Chemical compound O[Ti](O)(O)O LLZRNZOLAXHGLL-UHFFFAOYSA-J 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本願発明は、粉末化粧料、特に共存成分の安定性向上成分に関する。 The present invention relates to a powder cosmetic, particularly to a component for improving stability of a coexisting component.
粉末化粧料には、粉白粉やベビーパウダー、ボディパウダーのようなルースパウダータイプと、それに少量の賦形剤を添加して固めたプレスドパウダータイプがある。
これらは配合される粉末によって、化粧直し的な用途をはじめ、汗、皮脂を吸収する作用により皮膚をさっぱりとさせ健やかに保たせる等の用途で広く用いられている。また、香料の賦香率を上げることによって、香りを楽しむとともに、体臭を抑制する目的でも用いられている。
Powder cosmetics include loose powder types such as powdered white powder, baby powder, and body powder, and pressed powder types that are hardened by adding a small amount of excipients.
These powders are widely used in various applications such as retouching makeup and keeping the skin clean and healthy by absorbing sweat and sebum, depending on the powder to be blended. Moreover, it is used also for the purpose of suppressing a body odor while enjoying a fragrance by raising the fragrance rate of a fragrance | flavor.
粉末化粧料において、粉末成分として配合する体質顔料の配合量が多い場合、粉末の表面活性により香料が変質し、変臭を起こす場合があった。そこで、従来は、香料の変臭を防止するため、体質顔料に表面処理を施し、不活性化したものを用いる等の工夫がなされてきた。しかしながら、香料の種類によっては、これらの方法を用いても必ずしも香料の変臭を免れない場合があり、特に高温での香りの安定性に優れたものを得ることは困難であった。すなわち、本願発明は、体質顔料の配合量が多い場合においても香料の変質がない粉末化粧料を提供することを課題とする。 In powder cosmetics, when the amount of extender pigment blended as a powder component is large, the fragrance may be denatured due to the surface activity of the powder, which may cause a bad smell. Therefore, conventionally, in order to prevent the odor of the fragrance from being changed, the body pigment has been subjected to a surface treatment and used in an inactive manner. However, depending on the type of the fragrance, even if these methods are used, there is a case where the odor of the fragrance cannot be avoided, and it has been difficult to obtain a fragrance excellent in stability at a high temperature. That is, this invention makes it a subject to provide the powder cosmetics which do not change a fragrance | flavor even when there are many compounding quantities of an extender.
本願発明者は、上記の課題を解決するために鋭意検討を行った結果、ポリオキシエチレン硬化ヒマシ油の配合によって、体質顔料を多量に配合しても香料の変臭は起こらず、特に高温での香りの安定性が改善されることを見出し、本願発明を完成するに至った。すなわち、本願発明の粉末化粧料は、ポリオキシエチレン硬化ヒマシ油と、体質顔料を化粧料全量に対して60質量%以上と、香料とを含むことを特徴とする。 As a result of intensive studies to solve the above-mentioned problems, the inventors of the present application have not changed the fragrance of the fragrance even when blended with a large amount of extender pigment by blending polyoxyethylene hydrogenated castor oil, particularly at high temperatures. The present inventors have found that the stability of the scent is improved and have completed the present invention. That is, the powder cosmetic of the present invention includes polyoxyethylene hydrogenated castor oil, 60% by mass or more of the extender pigment based on the total amount of the cosmetic, and a fragrance.
また、本願発明の粉末化粧料において、体質顔料の種類は特に限定されないが、タルクであることが好適である。体質顔料の含有量は特に限定されないが、化粧料全量に対して60質量%以上の含有量の場合に、本願発明の効果が顕著に現れる。また、本願発明の粉末化粧料において、ポリオキシエチレン硬化ヒマシ油の配合量は特に限定されないが、好ましくは化粧料全量に対して0.01質量%以上5質量%以下、特に好ましくは0.1質量%以上2質量%以下である。0.01質量%未満では変臭防止効果が十分ではない場合があり、5質量%より多く配合すると、伸びの重さ、べたつき、さらさら感、化粧持ち等の使用性が損なわれる場合がある。 In the powder cosmetic of the present invention, the type of extender pigment is not particularly limited, but is preferably talc. The content of the extender pigment is not particularly limited, but when the content is 60% by mass or more based on the total amount of the cosmetic, the effect of the present invention is remarkably exhibited. In the powder cosmetic of the present invention, the amount of polyoxyethylene hydrogenated castor oil is not particularly limited, but is preferably 0.01% by mass or more and 5% by mass or less, and particularly preferably 0.1% by mass with respect to the total amount of the cosmetic. The mass is 2% by mass or more. If it is less than 0.01% by mass, the effect of preventing odor change may not be sufficient, and if it is added in an amount of more than 5% by mass, the usability such as the weight of elongation, stickiness, smooth feeling, and long-lasting makeup may be impaired.
本願発明に用いるポリオキシエチレン硬化ヒマシ油は、化粧料分野では主に乳化剤、可溶化剤等の用途で一般的に用いられている。ポリオキシエチレン硬化ヒマシ油は硬化ヒマシ油に、酸化エチレンを付加重合して得られる非イオン性界面活性剤である。化粧料の分野で利用されているポリオキシエチレン硬化ヒマシ油の酸化エチレンの付加モル数は3〜100である。本願発明に用いられるポリオキシエチレン硬化ヒマシ油の付加モル数は、特に限定されないが、好ましくは5〜80であり、最も好ましくは20〜60である。 The polyoxyethylene hydrogenated castor oil used in the present invention is generally used mainly in applications such as emulsifiers and solubilizers in the cosmetics field. Polyoxyethylene hydrogenated castor oil is a nonionic surfactant obtained by addition polymerization of ethylene oxide to hydrogenated castor oil. The number of moles of ethylene oxide added to polyoxyethylene hydrogenated castor oil used in the cosmetics field is 3 to 100. The number of added moles of the polyoxyethylene hydrogenated castor oil used in the present invention is not particularly limited, but is preferably 5 to 80, and most preferably 20 to 60.
以下、本願発明の好適な実施形態について説明する。本願発明における粉末化粧料は、粉末成分を主成分とする化粧料であり、粉末状のルースパウダータイプと、それに少量の賦形剤を添加して固めたプレスドパウダータイプがある。例えば、ルースパウダータイプには粉白粉、ベビーパウダー、ボディパウダー、フェイスパウダー等が挙げられ、プレスドパウダータイプには固型ファンデーション、頬紅、アイシャドー、アイブロウパウダー等が挙げられる。これらは配合される粉末によって、化粧直し的な用途をはじめ、汗、皮脂を吸収する作用により皮膚をさっぱりとさせ健やかに保たせる等の用途で広く用いられている。また、香料の賦香率を上げることによって、香りを楽しむとともに、体臭を抑制する目的でも用いられている。 Hereinafter, preferred embodiments of the present invention will be described. The powder cosmetic according to the present invention is a cosmetic mainly composed of a powder component, and includes a powdery loose powder type and a pressed powder type obtained by adding a small amount of excipients to the powdered loose powder type. For example, white powder, baby powder, body powder, face powder and the like are included in the loose powder type, and solid foundation, blusher, eye shadow, eyebrow powder and the like are included in the pressed powder type. These powders are widely used in various applications such as retouching makeup and keeping the skin clean and healthy by absorbing sweat and sebum, depending on the powder to be blended. Moreover, it is used also for the purpose of suppressing a body odor while enjoying a fragrance by raising the fragrance | flavor rate of a fragrance | flavor.
本願発明に配合される粉末成分としては、特に体質顔料があり、例えばタルク、カオリン、セリサイト、白雲母等が挙げられ、この中でもタルクを用いる場合に本願発明の効果が顕著である。粉末成分の配合量は特に限定されないが、香料の変臭が特に問題となるのは粉末成分が60質量%以上配合される場合であり、本願発明の効果が顕著に現れる。
粉末成分は、表面処理していないものも用いることができる。表面処理した粉末成分を用いる場合、表面処理の方法は特に限定されないが、金属石鹸、シリコーン類、脂肪酸エステル等の処理が例示される。
Examples of the powder component to be blended in the present invention include extender pigments such as talc, kaolin, sericite, muscovite, etc. Among them, the effect of the present invention is remarkable when talc is used. The blending amount of the powder component is not particularly limited, but the odor change of the fragrance is particularly problematic when the powder component is blended by 60% by mass or more, and the effect of the present invention is remarkably exhibited.
As the powder component, those not subjected to surface treatment can be used. In the case of using the surface-treated powder component, the surface treatment method is not particularly limited, but examples of the treatment include metal soap, silicones, and fatty acid esters.
本願発明において配合される香料としては、アルモアズ油、バージル油、ガルバナム油、ゼラニウム油、スペアミント油、イランイラン油、カルダモン油、エレミ油、ラベンダー油、ペパーミント油、ナツメグ油、カモミル油、ユーカリプタス油、ローズマリー油、アリルアミルグリコレート、1,1−ジメトキシ−2−フェニルエタン、2,4−ジメチル−4−フェニルテトラヒドロフラン、ジメチルテトラヒドロベンズアルデヒド、2,6−ジメチル−7−オクテン−2−オール、1,2−ジエトキシ−3,7−ジメチル−2,6−オクタジエン、フェニルアセトアルデヒド、ローズオキサイド、エチル−2−メチルペンタノエート、ラバンジン油、レモン油、ライム油、オレンジ油、プチグレン油、ベルガモット油、クラリセージ油、コリアンダー油、シプレス油、ジャスミンアブソリュート、ローズ油、ローズアブソリュート、1−(2,6,6−トリメチル−1,3−シクロヘキサジエン−1イル)−2−ブテン−1−オン、エチルバニリン、2,6−ジメチル−2−オクテノールと3,7−ジメチル−2−オクテノールとの混合物、第3級ブチルシクロヘキシルアセテート、アニシルアセテート、アリルシクロヘキシルオキシアセテート、エチルリナノール、オイゲノール、クマリン、エチルアセトアセテート、4−フェニル−2,4,6−トリメチル−1,3−ジオキサン、エチルアセトアセテートエチレングリコールケタール、4−メチレン−3,5,6,6−テトラメチル−2−ヘプタノン、エチルテトラヒドロサフラネート、ゲラニルニトリル、シス−3−ヘキセン−1−オール、シス−3−ヘキセニルアセテート、シス−3−ヘキセニルメチルカーボネート、2,6−ジメチル−5−ヘプテン−1−アール、4−(トリシクロ[5,2,1,02,6]デシリデン−8)ブタナール、5−(2,2,3−トリメチル−3−シクロペンテニル)−3−メチルペンタン−2−オール、p−第3級ブチル−α−メチルヒドロシンナミックアルデヒド、エチル[5,2,1,02,6]トリシクロデカンカルボキシレート、ゲラニオール、シトロネロール、シトラール等が挙げられる。このうち、リナリルアセテートを含有する香料の場合、本願発明の効果が顕著に現れる。リナリルアセテートは、ベルガモット油、ラベンダー油の主成分で、クラリセージ、ネロリ、ジャスミン、ガーデニア等の精油にも含まれる成分である。香料の配合量は特に限定されないが、固型ファンデーションやフェイスパウダー等であれば0.01〜1質量%、香りを楽しむ目的で使用するボディパウダーであれば1〜3質量%が通常配合される。 As perfumes to be blended in the present invention, armor oil, virgin oil, galvanum oil, geranium oil, spearmint oil, ylang ylang oil, cardamom oil, elemi oil, lavender oil, peppermint oil, nutmeg oil, camomil oil, eucalyptus oil, Rosemary oil, allyl amyl glycolate, 1,1-dimethoxy-2-phenylethane, 2,4-dimethyl-4-phenyltetrahydrofuran, dimethyltetrahydrobenzaldehyde, 2,6-dimethyl-7-octen-2-ol, 1 , 2-diethoxy-3,7-dimethyl-2,6-octadiene, phenylacetaldehyde, rose oxide, ethyl-2-methylpentanoate, lavandin oil, lemon oil, lime oil, orange oil, petitgren oil, bergamot oil, Clary sage oil, Liander oil, cypress oil, jasmine absolute, rose oil, rose absolute, 1- (2,6,6-trimethyl-1,3-cyclohexadien-1yl) -2-buten-1-one, ethyl vanillin, 2, Mixture of 6-dimethyl-2-octenol and 3,7-dimethyl-2-octenol, tertiary butyl cyclohexyl acetate, anisyl acetate, allyl cyclohexyl oxyacetate, ethyl linanol, eugenol, coumarin, ethyl acetoacetate, 4 -Phenyl-2,4,6-trimethyl-1,3-dioxane, ethyl acetoacetate ethylene glycol ketal, 4-methylene-3,5,6,6-tetramethyl-2-heptanone, ethyl tetrahydrosafranate, geranyl nitrile Cis-3-he Sen-1-ol, cis-3-hexenyl acetate, cis 3-hexenyl methyl carbonate, 2,6-dimethyl 5-heptene-1-al, 4- (tricyclo '5,2,1,0 2,6 Decylidene-8) butanal, 5- (2,2,3-trimethyl-3-cyclopentenyl) -3-methylpentan-2-ol, p-tertiary butyl-α-methylhydrocinnamic aldehyde, ethyl [ 5,2,1,0 2,6] tricyclodecane carboxylate, geraniol, citronellol, citral and the like. Among these, in the case of the fragrance | flavor containing a linalyl acetate, the effect of this invention appears remarkably. Linalyl acetate is a main component of bergamot oil and lavender oil, and is also a component contained in essential oils such as clary sage, neroli, jasmine, and gardenia. The blending amount of the fragrance is not particularly limited, but is usually 0.01 to 1% by mass for solid foundations and face powders, and 1 to 3% by mass for body powders used for the purpose of enjoying aroma. .
また、本願発明の粉末化粧料に配合可能な粉末としては、上記のほか、合成雲母、金雲母、紅雲母、黒雲母、バーミキュライト、炭酸マグネシウム、炭酸カルシウム、珪藻土、ケイ酸マグネシウム、ケイ酸カルシウム、ケイ酸アルミニウム、ケイ酸バリウム、ケイ酸ストロンチウム、タングステン酸金属塩、α−酸化鉄、水和酸化鉄、シリカ、ヒドロキシアパタイト等の無機粉末、ナイロンパウダー、ポリエチレンパウダー、ベンゾグアナミンパウダー、微結晶性セルロース、シリコーンパウダー等の有機粉末、酸化チタン、酸化鉄等の無機白色顔料、酸化鉄(ベンガラ)、チタン酸鉄等の無機赤色系顔料、黄酸化鉄、黄土等の無機黄色系顔料、マンゴバイオレット、コバルトバイオレット等の無機紫色系顔料、酸化クロム、水酸化クロム、コバルトチタン酸等の無機緑色系顔料、群青、紺青等の無機青色系顔料、酸化チタンコーテッド雲母、酸化チタンコーテッドオキシ酸化ビスマス、オキシ塩化ビスマス、酸化チタンコーテッドタルク、魚鱗箔、着色酸化チタンコーテッド雲母等のパール顔料、アルミニウムパウダー、カッパーパウダー等の金属粉末顔料が用いられ、さらに有機粉末に無機粉末を被覆した複合粉末、各種粉末を金属セッケン、シリコーン類、脂肪酸エステル等で疎水化処理した粉末も用いられる。 In addition to the above, the powders that can be blended in the powder cosmetic of the present invention include synthetic mica, phlogopite, sauroite, biotite, vermiculite, magnesium carbonate, calcium carbonate, diatomaceous earth, magnesium silicate, calcium silicate, Aluminum silicate, barium silicate, strontium silicate, metal tungstate, α-iron oxide, hydrated iron oxide, silica, hydroxyapatite and other inorganic powders, nylon powder, polyethylene powder, benzoguanamine powder, microcrystalline cellulose, Organic powders such as silicone powder, inorganic white pigments such as titanium oxide and iron oxide, inorganic red pigments such as iron oxide (Bengara) and iron titanate, inorganic yellow pigments such as yellow iron oxide and loess, mango violet, cobalt Inorganic purple pigments such as violet, chromium oxide, chromium hydroxide, Inorganic green pigments such as balt titanic acid, inorganic blue pigments such as ultramarine and bitumen, titanium oxide coated mica, titanium oxide coated bismuth oxyoxide, bismuth oxychloride, titanium oxide coated talc, fish scale foil, colored titanium oxide coated mica, etc. Pearl pigments, metal powder pigments such as aluminum powder, copper powder, etc., composite powders in which organic powders are coated with inorganic powders, and powders in which various powders are hydrophobized with metal soap, silicones, fatty acid esters, etc. are also used. It is done.
色素としては、赤色104号、黄色4号、緑色3号、青色1号、青色2号、赤色202号、赤色226号、赤色227号、赤色230号、橙色206号、橙色207号、黄色202号、緑色201号、緑色204号、青色201号、緑色205号等のタール色素、カルミン酸、ラッカイン酸、カルサミン、クロシン等の天然色素をレーキ化したもの等が用いられる。 As the pigment, red No. 104, yellow No. 4, green No. 3, blue No. 1, blue No. 2, red No. 202, red No. 226, red No. 227, red No. 230, orange No. 206, orange No. 207, yellow 202 No., green 201, green 204, blue 201, green 205 and the like, and lacquered natural pigments such as carminic acid, lacqueric acid, calsamine and crocin are used.
さらには上記のほかに目的に応じて本願発明の効果を損なわない量的、質的範囲内で、さらに油分、界面活性剤、保湿剤、防腐剤、薬剤等を配合してもよい。例えば、油分としては、流動パラフィン、ワセリン、パラフィンワックス、スクワラン、ミツロウ、カルナウバロウ、オリーブ油、ラノリン、高級アルコール、脂肪酸、高級アルコールと脂肪酸の合成エステル油、ジメチルポリシロキサン、デカメチルシクロペンタシロキサン等のシリコーン等が挙げられる。界面活性剤としては、ポリオキシアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステル、アルキルエーテル変性シリコーン等の非イオン界面活性剤等が挙げられる。保湿剤としては、ピロリドンカルボン酸ナトリウム、ヒアルロン酸、コンドロイチン硫酸塩、乳酸、乳酸ナトリウム等が挙げられる。防腐剤としては、パラオキシ安息香酸アルキルエステル、安息香酸ナトリウム、ソルビタンカリウム等が挙げられる。薬剤としては、ビタミンC、ビタミンE類等のビタミン類、各種アミノ酸、植物抽出物、生薬、抗酸化剤、抗菌剤、消炎剤等が挙げられる。 In addition to the above, according to the purpose, oil, surfactant, moisturizer, preservative, drug and the like may be further blended within a quantitative and qualitative range that does not impair the effects of the present invention. For example, oils include liquid paraffin, petrolatum, paraffin wax, squalane, beeswax, carnauba wax, olive oil, lanolin, higher alcohol, fatty acid, synthetic ester oil of higher alcohol and fatty acid, silicone such as dimethylpolysiloxane, decamethylcyclopentasiloxane, etc. Etc. Surfactants include polyoxyalkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil And nonionic surfactants such as polyoxyethylene sorbitol fatty acid esters and alkyl ether-modified silicones. Examples of the humectant include sodium pyrrolidone carboxylate, hyaluronic acid, chondroitin sulfate, lactic acid, sodium lactate and the like. Examples of the preservative include paraoxybenzoic acid alkyl ester, sodium benzoate, sorbitan potassium and the like. Examples of the drug include vitamins such as vitamin C and vitamin E, various amino acids, plant extracts, herbal medicines, antioxidants, antibacterial agents, anti-inflammatory agents, and the like.
本願発明をより詳しく説明するために、以下に実施例を挙げるが、本願発明はこれに限定されない。 In order to describe the present invention in more detail, examples are given below, but the present invention is not limited thereto.
実施例1〜4 フェイスパウダー
表1に示す処方にてフェイスパウダーを常法により製造した。併せて、表1に示す比較例1〜4を同様に製造した。なお、配合量は質量%で示す。
Examples 1-4 Face powder Face powder was manufactured by the usual method with the prescription shown in Table 1. In addition, Comparative Examples 1 to 4 shown in Table 1 were produced in the same manner. In addition, a compounding quantity is shown by the mass%.
上記のフェイスパウダーを室温、50℃の各温度で保存し、以下の評価基準にしたがって2週間後の香料の変臭について評価した。なお、評価は香料分野の専門パネルが行った。
評価基準
◎:変化しない
○:ほとんど変化しない
△:やや変化している
×:変化している
評価結果を表1に併せて示す。
Said face powder was preserve | saved at each temperature of room temperature and 50 degreeC, and the odor change of the fragrance | flavor after 2 weeks was evaluated according to the following evaluation criteria. The evaluation was conducted by a special panel in the perfume field.
Evaluation criteria ◎: No change ○: Almost no change Δ: Somewhat changed ×: Changed The evaluation results are also shown in Table 1.
表1より明らかなように、タルクとともに香料を配合すると、高温での貯蔵中に香りの劣化が生じる(比較例1〜4)。これに対し、ポリオキシエチレン硬化ヒマシ油を配合すると、変臭が抑制され、特に高温貯蔵時の香りの安定性が向上した(実施例1〜4)。また、タルクが60%を超えると、高温貯蔵時の香りの安定性がより低下するが、ポリオキシエチレン硬化ヒマシ油を配合すると、安定性が向上した。 As is apparent from Table 1, when a fragrance is blended together with talc, the fragrance is deteriorated during storage at a high temperature (Comparative Examples 1 to 4). On the other hand, when polyoxyethylene hydrogenated castor oil was blended, the odor change was suppressed, and the stability of the scent particularly during high-temperature storage was improved (Examples 1 to 4). Moreover, when talc exceeds 60%, the stability of the fragrance at the time of high-temperature storage is further lowered, but when polyoxyethylene hydrogenated castor oil is blended, the stability is improved.
実施例5〜9 フェイスパウダー
ポリオキシエチレン硬化ヒマシ油の配合量を変えて、表2に示す実施例5〜9、比較例4を上記と同様に製造し、50℃にて2週間保存の後、上記と同様に香料の変臭について評価した。また、以下の評価基準にしたがって使用性(伸びの重さ、べたつき、さらさら感、化粧持ち)について、総合的に評価した。なお、評価は化粧料分野の専門パネルが行った。
評価基準
◎:問題なし
○:ほぼ問題なし
△:やや劣る
×:劣る
Examples 5 to 9 Face powders Examples 5 to 9 and Comparative Example 4 shown in Table 2 were produced in the same manner as described above by changing the blending amount of polyoxyethylene hydrogenated castor oil, and stored at 50 ° C. for 2 weeks. In the same manner as above, the odor of the fragrance was evaluated. In addition, the usability (height of elongation, stickiness, smooth feeling, longevity) was comprehensively evaluated according to the following evaluation criteria. The evaluation was conducted by a specialist panel in the cosmetics field.
Evaluation criteria ◎: No problem ○: Almost no problem △: Somewhat inferior ×: Inferior
表2より明らかなように、ポリオキシエチレン硬化ヒマシ油の配合量は、0.1〜7質量%の範囲では50℃でのリナリルアセテートの変臭は見られず良好であった。0.01質量%未満では変臭防止効果が十分ではない場合があり、5質量%より多いと使用性がやや損なわれる場合がある。香り、使用性の点で特に好適な範囲は、0.01〜5質量%である。さらに好適な範囲は、0.1〜2質量%である。 As is clear from Table 2, the blended amount of polyoxyethylene hydrogenated castor oil was good in the range of 0.1 to 7% by mass with no odor of linalyl acetate at 50 ° C. If it is less than 0.01% by mass, the deodorizing effect may not be sufficient, and if it exceeds 5% by mass, the usability may be slightly impaired. A particularly preferred range in terms of fragrance and usability is 0.01 to 5% by mass. A more preferable range is 0.1 to 2% by mass.
実施例10〜15 フェイスパウダー
ポリオキシエチレン硬化ヒマシ油の付加モル数を変えて、表3に示す実施例10〜15及びポリオキシエチレン硬化ヒマシ油に換えてポリオキシエチレンセチルエーテル(40E.O.)を配合した比較例5を上記と同様に製造し、室温、40℃、50℃にて2週間保存の後、上記と同様に香料の変臭について評価した。
Examples 10-15 Face powder Polyoxyethylene cetyl ether (40E.O.) was replaced with Examples 10-15 and polyoxyethylene hydrogenated castor oil shown in Table 3 by changing the number of added moles of polyoxyethylene hydrogenated castor oil. ) Was prepared in the same manner as described above, and after storage at room temperature, 40 ° C., and 50 ° C. for 2 weeks, the odor of the fragrance was evaluated in the same manner as above.
表3より明らかなように、ポリオキシエチレン硬化ヒマシ油の付加モル数は、2〜100の範囲では室温でのリナリルアセテートの変臭は見られず良好であった。それに対しポリオキシエチレンセチルエーテル(40E.O.)は室温、40℃、50℃いずれの保管でも香料の変臭があった。40℃保管時ではポリオキシエチレン硬化ヒマシ油の付加モル数が、5〜80の範囲ではリナリルアセテートの変臭は見られず良好であった。50℃保管時ではポリオキシエチレン硬化ヒマシ油の付加モル数が、20〜60の範囲ではリナリルアセテートの変臭は見られず良好であった。この結果より、高温保管での香料の変臭抑制の点で、ポリオキシエチレン硬化ヒマシ油の付加モル数は特に好適な範囲は、5〜80である。さらに好適な範囲は、20〜60である。 As is clear from Table 3, the number of added moles of polyoxyethylene hydrogenated castor oil was good when no odor of linalyl acetate was observed at room temperature in the range of 2 to 100. On the other hand, polyoxyethylene cetyl ether (40E.O.) had a perfume odor change even when stored at room temperature, 40 ° C. or 50 ° C. When the polyoxyethylene hydrogenated castor oil was added in the range of 5 to 80 when stored at 40 ° C., no odor of linalyl acetate was observed, which was good. When the polyoxyethylene hydrogenated castor oil was added in the range of 20 to 60 when stored at 50 ° C., no deodorant of linalyl acetate was observed, which was good. From this result, the number of added moles of polyoxyethylene hydrogenated castor oil is particularly preferably 5 to 80 in terms of suppressing the odor change of the fragrance during high temperature storage. A more preferred range is 20-60.
以下、本願発明のより具体的な処方例について説明する。なお、以下の粉末化粧料はいずれも品質安定性に優れ、長期保存しても香料の変化が少なかった。
実施例16 ボディパウダー
成分 配合量(質量%)
1 タルク 90.0
2 酸化亜鉛 3.0
3 セリサイト 残量
4 防腐剤 適量
5 香料(ベルガモット油) 0.5
6 ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.4
計 100.0
[製造方法]成分1〜6を混合して製品とする。
Hereinafter, more specific prescription examples of the present invention will be described. In addition, all of the following powder cosmetics were excellent in quality stability, and even if stored for a long time, there was little change in the fragrance.
Example 16 Body powder Ingredient Amount (% by mass)
1 Talc 90.0
2 Zinc oxide 3.0
3 Remaining amount of sericite 4 Preservative appropriate amount 5 Perfume (bergamot oil) 0.5
6 Polyoxyethylene hydrogenated castor oil (60 EO) 0.4
Total 100.0
[Production Method] Components 1 to 6 are mixed to obtain a product.
実施例17 フェイスパウダー
成分 配合量(質量%)
1 タルク 60.0
2 マイカ 10.0
3 ナイロンパウダー 10.0
4 二酸化チタン 3.0
5 セリサイト 残量
6 防腐剤 適量
7 香料(ベルガモット油) 0.25
8 ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.5
計 100.0
[製造方法]成分1〜8を混合して製品とする。
Example 17 Face powder Ingredient Amount (% by mass)
1 Talc 60.0
2 Mica 10.0
3 Nylon powder 10.0
4 Titanium dioxide 3.0
5 Remaining amount of sericite 6 Preservative appropriate amount 7 Fragrance (bergamot oil) 0.25
8 Polyoxyethylene hydrogenated castor oil (40E.O.) 0.5
Total 100.0
[Production Method] Components 1 to 8 are mixed to obtain a product.
実施例18 固型ファンデーション
成分 配合量(質量%)
1 4%ハイドロゲンジメチコン処理タルク 65.0
2 2%メチコン処理マイカ 3.0
3 ナイロンパウダー 2.0
4 2%メチコン処理微粒子二酸化チタン 5.0
5 2%ジメチコン処理二酸化チタン 8.0
6 2%ジメチコン処理ベンガラ 0.5
7 2%ジメチコン処理黄酸化鉄 1.0
8 2%ジメチコン処理黒酸化鉄 0.2
9 スクワラン 3.0
10 固形パラフィン 0.5
11 ジメチルポリシロキサン 3.0
12 パラメトキシケイ皮酸エチルヘキシル 6.0
13 t−ブチルメトキシジベンゾイルメタン 2.0
14 セリサイト 残量
15 防腐剤 適量
16 香料(ラベンダー油) 0.25
17 ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.3
[製造方法]成分1〜17を混合して製品とする。
Example 18 Solid Foundation Ingredient Amount (% by mass)
14% hydrogen dimethicone-treated talc 65.0
2 Micacon treated mica 3.0%
3 Nylon powder 2.0
4 2% methicone-treated fine particle titanium dioxide 5.0
5 2% dimethicone-treated titanium dioxide 8.0
6 2% dimethicone treated bengara 0.5
7 2% Dimethicone-treated yellow iron oxide 1.0
8 2% Dimethicone-treated black iron oxide 0.2
9 Squalane 3.0
10 Solid paraffin 0.5
11 Dimethylpolysiloxane 3.0
12 Ethylhexyl paramethoxycinnamate 6.0
13 t-Butylmethoxydibenzoylmethane 2.0
14 Sericite Remaining 15 Preservative Appropriate 16 Perfume (lavender oil) 0.25
17 Polyoxyethylene hydrogenated castor oil (40E.O.) 0.3
[Production Method] Components 1 to 17 are mixed to obtain a product.
実施例19 頬紅
成分 配合量(質量%)
1 タルク 70.0
2 マイカ 10.0
3 二酸化チタン 5.0
4 雲母チタン 5.0
5 ベンガラ 1.0
6 赤色226号 0.5
7 流動パラフィン 5.0
8 セリサイト 残量
9 防腐剤 適量
10 香料(ラベンダー油) 0.1
11 ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.3
[製造方法]成分1〜11を混合して製品とする。
Example 19 Blusher Ingredient Amount (mass%)
1 Talc 70.0
2 Mica 10.0
3 Titanium dioxide 5.0
4 Mica titanium 5.0
5 Bengala 1.0
6 Red 226 0.5
7 Liquid paraffin 5.0
8 Remaining amount of sericite 9 Preservative Appropriate amount 10 Perfume (lavender oil) 0.1
11 Polyoxyethylene hydrogenated castor oil (60 EO) 0.3
[Production Method] Components 1 to 11 are mixed to obtain a product.
本願発明の粉末化粧料は、ポリオキシエチレン硬化ヒマシ油を配合することにより、粉末成分の表面活性による香料の変質を防止することができ、香りの安定性を向上させることができる。 By blending polyoxyethylene hydrogenated castor oil, the powder cosmetic of the present invention can prevent the perfume from being altered by the surface activity of the powder component, and can improve the stability of the scent.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012197203A JP6022268B2 (en) | 2012-09-07 | 2012-09-07 | Powder cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012197203A JP6022268B2 (en) | 2012-09-07 | 2012-09-07 | Powder cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014051457A true JP2014051457A (en) | 2014-03-20 |
JP6022268B2 JP6022268B2 (en) | 2016-11-09 |
Family
ID=50610296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012197203A Active JP6022268B2 (en) | 2012-09-07 | 2012-09-07 | Powder cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6022268B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021515055A (en) * | 2018-03-05 | 2021-06-17 | フイルメニツヒ ソシエテ アノニムFirmenich Sa | Powdered composition containing fire protection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63215614A (en) * | 1987-03-04 | 1988-09-08 | Shiseido Co Ltd | Make-up cosmetic |
JP2000136176A (en) * | 1998-10-28 | 2000-05-16 | Chemiprokasei Kaisha Ltd | Polymethine compound, its production method and use |
JP2008007442A (en) * | 2006-06-28 | 2008-01-17 | Univ Kanagawa | Cosmetics |
WO2011076518A1 (en) * | 2009-12-26 | 2011-06-30 | Evonik Degussa Gmbh | Water containing powder composition |
JP2012140388A (en) * | 2011-01-06 | 2012-07-26 | Kao Corp | Skin care preparation |
JP2012144580A (en) * | 2012-05-08 | 2012-08-02 | Asahi Kasei Chemicals Corp | Oil film-forming emulsified composition |
-
2012
- 2012-09-07 JP JP2012197203A patent/JP6022268B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63215614A (en) * | 1987-03-04 | 1988-09-08 | Shiseido Co Ltd | Make-up cosmetic |
JP2000136176A (en) * | 1998-10-28 | 2000-05-16 | Chemiprokasei Kaisha Ltd | Polymethine compound, its production method and use |
JP2008007442A (en) * | 2006-06-28 | 2008-01-17 | Univ Kanagawa | Cosmetics |
WO2011076518A1 (en) * | 2009-12-26 | 2011-06-30 | Evonik Degussa Gmbh | Water containing powder composition |
JP2012140388A (en) * | 2011-01-06 | 2012-07-26 | Kao Corp | Skin care preparation |
JP2012144580A (en) * | 2012-05-08 | 2012-08-02 | Asahi Kasei Chemicals Corp | Oil film-forming emulsified composition |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021515055A (en) * | 2018-03-05 | 2021-06-17 | フイルメニツヒ ソシエテ アノニムFirmenich Sa | Powdered composition containing fire protection |
JP7346405B2 (en) | 2018-03-05 | 2023-09-19 | フイルメニツヒ ソシエテ アノニム | Powdered composition containing fire retardant |
US11773328B2 (en) | 2018-03-05 | 2023-10-03 | Firmenich Sa | Powdered composition comprising a fireproofing agent |
Also Published As
Publication number | Publication date |
---|---|
JP6022268B2 (en) | 2016-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8518385B2 (en) | Antiperspirant composition based on dicarboxylic acid diesters of a C6-C18 dicarboxylic acid with C12-C22 fatty alcohols | |
KR101182693B1 (en) | Sunscreen cosmetic | |
JP6725470B2 (en) | Cosmetics | |
JP4970805B2 (en) | Topical skin preparation | |
JP6022268B2 (en) | Powder cosmetics | |
JP5346533B2 (en) | Powdered solid antiperspirant deodorant | |
JP5389573B2 (en) | Two-layer cosmetic | |
JP6644415B2 (en) | Body odor suppressant | |
JP2011079780A (en) | Powder cosmetic | |
TW202440130A (en) | Composition | |
JP6338936B2 (en) | Liquid odor control agent | |
JP3660537B2 (en) | Powder cosmetics | |
JP5562816B2 (en) | Stick-like emulsified composition | |
JP6618401B2 (en) | Emulsion odor control agent | |
JP6644416B2 (en) | Composition for suppressing body odor | |
JP2014043404A (en) | Powder cosmetic | |
JP2010168286A (en) | Solid powder cosmetic | |
JP6284437B2 (en) | Body odor suppressor | |
JP4895289B2 (en) | Stick cosmetic | |
JP6554287B2 (en) | Wet solid powder cosmetic | |
JP5595749B2 (en) | Powder cosmetics | |
JP6632210B2 (en) | Masking composition | |
JP2010235759A (en) | Oily solid perfume composition | |
JP2011057658A (en) | Cosmetic | |
JP2003104831A (en) | Skin care preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150716 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160425 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160517 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160630 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160711 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161004 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161005 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6022268 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |